S5.12 In the blood: using circulating DNA to detect and monitor cancer
Genetics Unzipped
00:00
The Limitations of City Dela in Cancer Research
We are using city dela in three ways. The first sort of area of fuson interest to us and many others, is this area of early diagnosis or early detection. Can we use sitidionam to detect tumors in blood before they presented symptomatically? And you and i know how important that is. Second error is in this clinical scenario, which we call minimal residual disease. So following surgery, we hope to cure the majority of patients with early stage lung cancer. But we still know that some patients tumus will come back. We end up treating almost all patients with stage two and stage three cancer with adjuvant cemotherapy,. To mop up any residual cancer
Transcript
Play full episode
